Crinetics Pharmaceuticals Announces 2021 Clinical Plans and Reports Fourth Quarter and Full Year 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TSLA
3. TXN
4. NOW
5. AMD
6. GOOG
7. INTC
8. CSX
9. IBM
10. KNX

Go back to Crinetics Pharmaceuticals Announces 2021 Clinical Plans and Reports Fourth Quarter and Full Year 2020 Financial Results

Crinetics Pharmaceuticals (CRNX) Reports Q4 Loss of $0.66/sh

March 30, 2021 4:13 PM EDT

Crinetics Pharmaceuticals (NASDAQ: CRNX) reported Q4 EPS of ($0.66), versus ($0.60) reported last year.

For earnings history and earnings-related data on Crinetics Pharmaceuticals (CRNX) click here.

... More